search button

Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study

  • Authors:
    • Qiang‑Sheng Dai
    • Hong‑Lin Gu
    • Sheng Ye
    • Yao‑Jun Zhang
    • Xiao‑Jun Lin
    • Wan Yee Lau
    • Zhen‑Wei Peng
    • Min‑Shan Chen

  • View Affiliations

  • Published online on: August 18, 2014     https://doi.org/10.3892/mco.2014.391
  • Pages: 1047-1054
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

This study was conducted to compare long‑term survival between patients with unresectable infiltrating hepatocellular carcinoma (HCC) who were treated with transarterial chemoembolization (TACE) and those who received conservative treatment (best supportive care). Between January, 2007 and January, 2012, a total of 131 consecutive patients with unresectable infiltrating HCC underwent TACE in a cancer center (TACE group), while 156 similar consecutive HCC patients received conservative treatment in another cancer center (conservative treatment group). The diagnosis of unresectable infiltrating HCC was established by agreement between two radiologists coming from the two centers, who performed an independent review of all the cross‑sectional imagings of the patients. The two groups were comparable regarding patient characteristics, preoperative liver function, tumor burden and general condition. In the TACE group, 52 patients received one session and 79 patients received more than one session of TACE (mean, 1.5 and range, 1‑4 sessions). There was no reported TACE‑related mortality. The 1‑month mortality rate was 0.8 and 3.8% in the TACE and the conservative groups, respectively (p=0.134). The median survival for the TACE and conservative treatment groups was 7.0 and 3.0 months, respectively. The 6‑, 12‑ and 24‑month overall survival rates for the TACE and conservative treatment groups were 61.7, 18.5 and 2.3% vs. 22.7, 12.1 and 0%, respectively (p<0.001). On multivariate analysis, treatment allocation [odds ratio (OR)=1.777; 95% confidence interval (CI): 1.499‑2.107; p<0.001] and portal vein tumor thrombosis (OR=1.721; 95% CI: 1.504‑1.907; p<0.001) were independent predictors of overall survival. In conclusion, TACE was found to be a safe and feasible treatment option for patients with unresectable infiltrating HCC and it conferred survival benefit over conservative treatment.
View Figures
View References

Related Articles

Journal Cover

November-December 2014
Volume 2 Issue 6

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 1.4
  • Ranked
    (total number of cites)
  • CiteScore: 2.8
  • CiteScore Rank: Q3: #250/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.55
  • SCImago Journal Rank (SJR): 0.446
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Dai QS, Gu HL, Ye S, Zhang YJ, Lin XJ, Lau WY, Peng ZW and Chen MS: Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study. Mol Clin Oncol 2: 1047-1054, 2014.
APA
Dai, Q., Gu, H., Ye, S., Zhang, Y., Lin, X., Lau, W.Y. ... Chen, M. (2014). Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study. Molecular and Clinical Oncology, 2, 1047-1054. https://doi.org/10.3892/mco.2014.391
MLA
Dai, Q., Gu, H., Ye, S., Zhang, Y., Lin, X., Lau, W. Y., Peng, Z., Chen, M."Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study". Molecular and Clinical Oncology 2.6 (2014): 1047-1054.
Chicago
Dai, Q., Gu, H., Ye, S., Zhang, Y., Lin, X., Lau, W. Y., Peng, Z., Chen, M."Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study". Molecular and Clinical Oncology 2, no. 6 (2014): 1047-1054. https://doi.org/10.3892/mco.2014.391